Source: Envigo Blog

Envigo Blog The fine art of contract breeding

The quality of preclinical research is key to the successful translation of new drugs to the clinic. An important driver of this quality is a healthy, meticulously managed, and accurately characterized animal colony. To achieve this requires dedication and experience, and success depends critically on state-of-the-art facilities, expertise in technologies and colony management practices, as well as comprehensive health and genetic monitoring protocols. How can researchers ensure flexible access to a reliable supply of these high-quality models? Well, there’s an art to it.  

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Adrian Hardy's photo - President & CEO of Envigo

President & CEO

Adrian Hardy

CEO Approval Rating

88/100

Read more